Search Results 211-220 of 19345 for B cell lymphomas
He went in for some tests at a local hospital, where he got a diagnosis he did not expect. Doctors told Bill he had large B cell lymphoma, a type of blood ...
... B-cell lymphomas who have failed 1-2 prior lines of therapy. The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol ...
Developing the first genetic test to help guide the diagnosis and treatment of people with diffuse large B-cell lymphoma, the most common type of non-Hodgkin ...
Stat3 inhibition augments the immunogenicity of B-cell lymphoma cells, leading to effective antitumor immunity Cancer Res.2012;72:(17)4440-8. Horna P, Olteanu H ...
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...
Acute lymphocytic leukemia (ALL) is a type of cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made.
Axicabtagene ciloleucel injection is used to treat follicular lymphoma and large B-cell lymphoma (including diffuse large B-cell lymphoma [DLBCL], primary ...
... cell leukemia, Follicular lymphoma, Burkitt lymphoma, B-cell lymphoma ... cell lymphoma, Follicular lymphoma, B-cell lymphoma, T-cell lymphoma. Show ...
... B-cell lymphoma-2 (Bcl-2) inhibitor. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 1/8/24. Questions ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.